<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

Cenobamate's Efficacy in Drug-Resistant Epilepsy: Jacob Pellinen, MD

Default sub title

minute read

Written by Neurology Live on April 14, 2024

Recent research shows that approximately 42% to 63% of patients with drug-resistant epilepsy who undergo surgery still have seizures in 1 year after surgery although surgery for this patient population has shown to be superior to medical management.

Topics: Press Coverage

Related Stories